Related Experiment Videos
bFGF as an autocrine growth factor for human melanomas
1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Summary
Metastatic melanomas exhibit constitutive basic fibroblast growth factor (bFGF) activity, unlike normal melanocytes. This suggests bFGF acts as an autocrine growth factor in melanoma progression.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Normal human melanocytes require specific growth factors like basic fibroblast growth factor (bFGF) for proliferation in culture.
- Metastatic melanoma cells exhibit distinct growth factor requirements, proliferating in standard media and producing bFGF-related substances.
Purpose of the Study:
- To investigate the presence and role of mitogenic activity, specifically related to bFGF, in human metastatic melanomas.
- To determine if melanoma cells express bFGF gene transcripts and if bFGF functions as an autocrine growth factor.
Main Methods:
- Comparing the proliferative capacity of normal melanocytes and melanoma cells in different culture media.
- Assessing the effect of anti-bFGF antibodies on melanoma cell mitogenic activity.
- Analyzing bFGF gene transcript expression in both normal melanocytes and melanoma cells.
Main Results:
- Human metastatic melanomas possess constitutive mitogenic activity essential for normal melanocyte growth.
- This activity in melanomas is neutralized by anti-bFGF antibodies.
- Melanoma cells, but not normal melanocytes, express bFGF gene transcripts.
Conclusions:
- Basic fibroblast growth factor (bFGF) is constitutively expressed and likely acts as an autocrine growth factor in human metastatic melanomas.
- The abnormal expression of bFGF contributes to the uncontrolled proliferation characteristic of melanomas.